ERBB2 and non-small cell lung carcinoma: The majority of HER2 mutations in NSCLC comprise insertions or missense mutations located in exons 18–20 and similarly to mutations in EGFR, which primarily involve exons 18–21, they affect the αC-helix and loop part of the kinase domain (Figure 1) [31,32].